ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in New York, NY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Triple Negative Breast Cancer
Lung Cancer

Endometrial Cancer trials near New York, NY, USA:

A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)

This research study is studying a drug combination as a possible treatment for endometrial cancer.The drugs involved in this study ...

Active, not recruiting
Endometrial Cancer
Drug: Pembrolizumab
Drug: IMGN853

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Lake Success, New York, United States and 2 other locations

A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer...

Enrolling
Endometrial Cancer
Endometrioid Endometrial Cancer
Drug: nab-sirolimus

Phase 2

Aadi Bioscience

New York, New York, United States and 8 other locations

and Femara (letrozole) can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will al...

Active, not recruiting
Endometrial Cancer
Drug: RAD001 (Everolimus)
Drug: Letrozole

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Morristown, New Jersey, United States and 1 other location

This is a a Simon's two-stage, non-randomized, open label, 2-arm Phase II trial of ONC201 in women with metastatic or recurrent Type II endometrial...

Active, not recruiting
Endometrial Cancer Recurrent
Drug: ONC201

Phase 2

Chimerix
Chimerix

New Brunswick, New Jersey, United States and 2 other locations

This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune check ...

Enrolling
Endometrial Cancer
Drug: Talazoparib
Drug: Bevacizumab

Phase 1, Phase 2

Alliance Foundation Trials

New York, New York, United States and 19 other locations

letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...

Active, not recruiting
Endometrial Cancer
Drug: Abemaciclib
Drug: Letrozole

Phase 2

Gynecologic Oncology Group (GOG)

New York, New York, United States and 28 other locations

study is designed to evaluate the efficacy, safety, and pharmacokinetics of giredestrant monotherapy in participants with Grade 1 endometrioid endometrial...

Enrolling
Endometrial Cancer
Drug: Giredestrant

Phase 2

Roche
Roche

Englewood, New Jersey, United States and 18 other locations

The primary objectives of this study are to compare sacituzumab tirumotecan to Treatment of Physician's Choice (TPC) with respect to progression-free...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Doxorubicin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

New York, New York, United States and 107 other locations

This study will test whether the combination of radiation and Dostarlimab is an effective treatment for women with MMR-D/MSI-H endometrial c...

Active, not recruiting
Endometrial Cancer
Drug: Dostarlimab
Radiation: Intensity modulated radiation therapy (IMRT)

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

New York, New York, United States and 6 other locations

(ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial...

Enrolling
Endometrioid Endometrial Cancer
Drug: Letrozole 2.5mg
Drug: Narazaciclib

Phase 1, Phase 2

Onconova Therapeutics
Onconova Therapeutics

New York, New York, United States and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems